DLA
CELG

Douglas Lane & Associates’s Celgene Corp CELG Stock Holding History

Douglas Lane & Associates’s Portfolio CELG Stock Details CELG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		– Sell
-731,126
Closed -$72.6M – 221
2019
Q3 		$72.6M Sell
731,126
-8,139
-1% -$773K 1.45% 21
2019
Q2 		$68.3M Sell
739,265
-43,785
-6% -$4.16M 1.33% 29
2019
Q1 		$73.9M Sell
783,050
-76,164
-9% -$6.66M 1.53% 21
2018
Q4 		$55.1M Buy
859,214
+42,336
+5% +$3.13M 1.3% 27
2018
Q3 		$73.1M Buy
816,878
+60,914
+8% +$5.38M 1.44% 21
2018
Q2 		$60M Buy
755,964
+153,745
+26% +$12.8M 1.27% 32
2018
Q1 		$53.7M Buy
602,219
+106,765
+22% +$10.2M 1.17% 34
2017
Q4 		$51.7M Buy
495,454
+109,564
+28% +$12.4M 1.09% 42
2017
Q3 		$56.3M Sell
385,890
-9,832
-2% -$1.34M 1.29% 31
2017
Q2 		$51.4M Buy
395,722
+3,729
+1% +$457K 1.21% 33
2017
Q1 		$48.8M Buy
391,993
+11,419
+3% +$1.37M 1.22% 29
2016
Q4 		$44.1M Buy
380,574
+25,010
+7% +$2.79M 1.12% 37
2016
Q3 		$37.2M Buy
355,564
+27,340
+8% +$2.96M 0.99% 41
2016
Q2 		$32.4M Buy
328,224
+4,947
+2% +$512K 0.93% 45
2016
Q1 		$32.4M Buy
+323,277
New +$33.3M 0.88% 44

Other funds holding CELG

FP
Factorial Partners Mt. Kisco, New York $138M AUM 25.59% 1-Year Est. Return
HCM
Howard Capital Management Roswell, Georgia $8.4B AUM 51.89% 1-Year Est. Return
PCMC
Private Capital Management (Colorado) Denver, Colorado $501M AUM 17.09% 1-Year Est. Return
WCG
Weaver Consulting Group Huntington Beach, California $488M AUM 17.59% 1-Year Est. Return

Douglas Lane & Associates's CELG Position: Q4 2019 in Review

Douglas Lane & Associates sold out of Celgene Corp (CELG) in Q4 2019, closing a stake of 731,126 shares — an estimated $72.6M sold.

Douglas Lane & Associates first reported a position in CELG in Q1 2016 and held it in 15 quarters. The position peaked at $73.9M in Q1 2019. 4 funds tracked by Wall St. Rank hold CELG as of Q4 2019.

  • Douglas Lane & Associates reported no remaining Celgene Corp position as of Q4 2019 after selling out during the quarter.
  • Douglas Lane & Associates sold 731,126 Celgene Corp shares in Q4 2019, an estimated $72.6M.
  • Douglas Lane & Associates first reported a position in Celgene Corp in Q1 2016 and held it in 15 quarters.
  • Douglas Lane & Associates's Celgene Corp position peaked at $73.9M in Q1 2019.
  • 4 funds tracked by Wall St. Rank held Celgene Corp as of Q4 2019.

Based on Douglas Lane & Associates's 13F filing for Q4 2019, filed 27 Jan 2020.